Search Results - Gavin Giovannoni

Refine Results
  1. 1
    Neutralising antibodies to interferon beta during the treatment of multiple sclerosis

    Neutralising antibodies to interferon beta during the treatment of multiple sclerosis by Gavin Giovannoni

    Published 2002
    Get full text Get full text
    Editorial
    Save to List
    Saved in:
  2. 2
    Multiple sclerosis related fatigue

    Multiple sclerosis related fatigue by Gavin Giovannoni

    Published 2005
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  3. 3
    Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

    Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies by Gavin Giovannoni

    Published 2000
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Efficacy and Safety of Existing and Emerging Monoclonal Antibody Therapies for Multiple Sclerosis

    Efficacy and Safety of Existing and Emerging Monoclonal Antibody Therapies for Multiple Sclerosis by Gavin Giovannoni

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Cladribine to Treat Relapsing Forms of Multiple Sclerosis

    Cladribine to Treat Relapsing Forms of Multiple Sclerosis by Gavin Giovannoni

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19

    Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19 by Gavin Giovannoni

    Published 2020
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  7. 7
    Multiple sclerosis – a review

    Multiple sclerosis – a review by Ruth Dobson, Gavin Giovannoni

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review

    Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review by Gavin Giovannoni, Joela Mathews

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Multiple sclerosis: a practical overview for clinicians

    Multiple sclerosis: a practical overview for clinicians by Konrad Rejdak, Sam Jackson, Gavin Giovannoni

    Published 2010
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis

    Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis by Ruth Dobson, Vilija Jokubaitis, Gavin Giovannoni

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Fingolimod modulates microglial activation to augment markers of remyelination

    Fingolimod modulates microglial activation to augment markers of remyelination by Samuel J. Jackson, Gavin Giovannoni, David Baker

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects

    Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects by Jerold Chun, Gavin Giovannoni, Samuel F. Hunter

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Oral contraceptive induced chorea: another condition associated with anti-basal ganglia antibodies: Table 1

    Oral contraceptive induced chorea: another condition associated with anti-basal ganglia antibodies: Table 1 by M Miranda, Francisco Cardoso, Gavin Giovannoni, Andrew J. Church

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Depletion of <scp>CD</scp>52‐positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune‐tolerance promoting <scp>CD</scp>8 T‐cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis

    Depletion of <scp>CD</scp>52‐positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune‐tolerance promoting <scp>CD</scp>8 T‐cell p... by Stephanie von Kutzleben, Gareth Pryce, Gavin Giovannoni, David Baker

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Epstein-Barr–negative MS: a true phenomenon?

    Epstein-Barr–negative MS: a true phenomenon? by Ruth Dobson, Jens Kühle, Jaap M. Middeldorp, Gavin Giovannoni

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis

    “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis by Gavin Giovannoni, Davorka Tomic, Jeremy R. Bright, Eva Havrdová

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    Vitamin D supplementation

    Vitamin D supplementation by Ruth Dobson, Hannah R. Cock, Peter Brex, Gavin Giovannoni

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    BMI and low vitamin D are causal factors for multiple sclerosis

    BMI and low vitamin D are causal factors for multiple sclerosis by Benjamin Meir Jacobs, Alastair Noyce, Gavin Giovannoni, Ruth Dobson

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Systematic review and meta-analysis of the association between Epstein–Barr virus, multiple sclerosis and other risk factors

    Systematic review and meta-analysis of the association between Epstein–Barr virus, multiple sclerosis and other risk factors by Benjamin Meir Jacobs, Gavin Giovannoni, Jack Cuzick, Ruth Dobson

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Incidence of anti-brain antibodies in children with obsessive–compulsive disorder

    Incidence of anti-brain antibodies in children with obsessive–compulsive disorder by Russell C. Dale, Isobel Heyman, Gavin Giovannoni, Andrew J. Church

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: